LEAVITT PARTNERS, LLC

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $30,000.00 income · posted Apr 20, 2026

Bills named in this filing 2

Lobbying activity 1

Health Issues

Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.